Pilot Pen G2 Edge

Walmart, McKesson add generics to drug distribution pact

Print Friendly, PDF & Email

The expanded relationship is “a natural next step”

Walmart, McKesson add generics to drug distribution pact

BENTONVILLE, Ark. — Walmart and McKesson Corp. have expanded their long-term pharmaceutical distribution pact, including a new sourcing agreement for generic drugs.

McKesson and Walmart said Monday that the expanded relationship is “a natural next step.” The companies will collaborate on sourcing generics for their U.S. operations, a move that they said will add scale and value for both organizations.

“McKesson and Walmart have worked together for decades, and throughout our relationship both companies have engaged in an ongoing dialogue about how we can work together to bring more efficiency and value to the health care supply chain,” McKesson U.S. Pharmaceutical president Mark Walchirk said in a statement. “Expanding our relationship to include a sourcing partnership for generics makes economic and strategic sense for both of us. By bringing together our respective scale and sourcing expertise, we will make our businesses stronger and create more value for our customers and patients.”

The companies noted that the new sourcing agreement leverages McKesson’s strength and expertise in the global pharmaceuticals sector and Walmart’s range of accessible, affordable health and wellness services.

“Walmart and McKesson have built a strong business relationship over the past 30 years by working together to help lower the cost of health care,” stated George Riedl, senior vice president and president of health and wellness at Walmart U.S. “The dynamics of health care continue to change, and we’re changing with it. It’s why we are taking our relationship with McKesson to the next level, using our combined size and scale to drive efficiencies, something that is core to our business.”


ECRM_06-01-22


You must be logged in to post a comment Login